AI Terminal
Mutares SE & Co. KGaA
M&A Activity • Jul 1, 2025
6316_rns_2025-07-01_24aea8c0-56d4-458f-ba8d-6bd2d5d74a5a.html
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 1 July 2025 07:30
Mutares SE & Co. KGaA: Portfolio company Locapharm (former Alcura France) has completed the divestment of its care services activity in mainland France
Mutares SE & Co. KGaA / Key word(s): Investment
Mutares SE & Co. KGaA: Portfolio company Locapharm (former Alcura France) has completed the divestment of its care services activity in mainland France
01.07.2025 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Mutares SE & Co. KGaA: Portfolio company Locapharm (former Alcura France) has completed the divestment of its care services activity in mainland France
Munich, July 01, 2025 – Locapharm (former Alcura France), a 100% subsidiary of Mutares SE & Co. KGaA (ISIN: DE000A2NB650 ), has completed the divestment of its home healthcare services activity in mainland France – referred to as PSAD ( Prestations de Santé à Domicile ) – to Santé Cie Group, a leading European player of homecare and ambulatory care.
Since December 2024, the management team of the company, supported by operational experts from Mutares, has defined and launched several key measures to carve-out the business from its former shareholder Alliance Healthcare, rebrand it to its historical name Locapharm, focus on its core MAD ( maintien à domicile ) activities and start the implementation of a build-up strategy with two acquisitions already announced in May and June 2025.
Company profile of Mutares SE & Co. KGaA
Mutares SE & Co. KGaA, Munich (www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process.
The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol “MUX” (ISIN: DE000A2NB650) and are part of the selection index SDAX.
For more information, please contact:
Mutares SE & Co. KGaA
Investor Relations
Phone: +49 89 9292 7760
E-mail: [email protected]
Press Contact in Germany
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone: +49 89 125 09 0333
E-mail: [email protected]
Press Contact in France
CLAI
Matthieu Meunier
Phone: +33 06 26 59 49 05
E-mail: [email protected]
Press Contact in UK
14:46 Consulting
Tom Sutton
Phone: +44 7796 474940
E-mail: [email protected]
01.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Mutares SE & Co. KGaA |
| Arnulfstr.19 | |
| 80335 Munich | |
| Germany | |
| Phone: | +49 (0)89-9292 776-0 |
| Fax: | +49 (0)89-9292 776-22 |
| E-mail: | [email protected] |
| Internet: | www.mutares.de |
| ISIN: | DE000A2NB650 |
| WKN: | A2NB65 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2162794 |
| End of News | EQS News Service |
2162794 01.07.2025 CET/CEST